Brief: Shanghai Fosun's Unit in Collaboration With Sandoz AG on 10 Biologic Products
BRIEF-Shanghai Fosun's Unit in Collaboration With Sandoz AG on 10 Biologic Products Aug 17 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:
SAYS UNIT SIGNS FRAMEWORK COOPERATION AGREEMENT WITH SANDOZ AG
SAYS TO TEAM UP SANDOZ ON COMMERCIALIZATION, DEVELOPMENT, MANUFACTURING OF UP TO 10 BIOLOGIC PRODUCTS
Further company coverage: 600196.SS
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on Shanghai Fosun Pharmaceutical
See all newsSHH Margin Trading -- Fosun Pharma Margin Long Amount is 1,592 (x10000) yuan, Short Selling Volume is 5 (x10000) shares
SHH Margin Trading -- Fosun Pharma Margin Long Amount is 2,031 (x10000) yuan, Short Selling Volume is 1 (x10000) shares
SHH Margin Trading -- Fosun Pharma Margin Long Amount is 2,109 (x10000) yuan, Short Selling Volume is 10 (x10000) shares
SHH Margin Trading -- Fosun Pharma Margin Long Amount is 2,131 (x10000) yuan, Short Selling Volume is 0.21 (x10000) shares
SHH Margin Trading -- Fosun Pharma Margin Long Amount is 1,865 (x10000) yuan, Short Selling Volume is 0.15 (x10000) shares